-
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: Results from REDUCE-IT
Burger, P. M., Bhatt, D. L., Dorresteijn, J. A. N., Koudstaal, S., Mosterd, A., Martens, F. M. A. C., Steg, P. G., Visseren, F. L. J. & REDUCE-IT Investigators, 1 Sept 2024, In: European Heart Journal - Cardiovascular Pharmacotherapy. 10, 6, p. 488-499 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
